Clinical Trial Update: Levocarnitine in Treating Fatigue in Cancer Patients [Phase 3]

View source ↗

Summary

Phase 3 trial assessing levocarnitine for fatigue in cancer patients has completed with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer-related Fatigue
• Unspecified Adult Solid Tumor

Drugs mentioned

• LEVOCARNITINE (levocarnitine)

Snippet

Sponsor: ECOG-ACRIN Cancer Research Group | Conditions: Fatigue, Unspecified Adult Solid Tumor, Protocol Specific | Phase 3 | Status: COMPLETED | Results posted: 2016-05-30